Ecopharmacovigilance and pharmacovigilance: an analysis of environment-related reporting in VigiBase

FormulationDE: an updated artificial intelligence system for drug-excipient compatibility prediction

US Food and Drug Administration Sentinel Initiative and Postmarket Drug Safety Surveillance

Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase

Oncofertility Pharmacovigilance in Women Receiving Immune Checkpoint Inhibitors: Reproductive Risks, Fertility Preservation, and Pregnancy Outcomes

Real-World Safety Profile of Levofloxacin: Pharmacovigilance Signals, Co-Medication Patterns, and Signal Validation

Precision and Personalized Medicine in Transdermal Drug Delivery Systems: Integrating AI Approaches

Hematological toxicities and thrombosis risk associated with immune checkpoint inhibitors: a pharmacovigilance study from 2014 to 2024

Active surveillance of drug safety in healthcare data: Sequential monitoring of bacterial and serious urinary tract infection risk in sodium-glucose cotransporter 2 inhibitor users

Age-Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

Global Pharmacovigilance of Aesthetic Botulinum Toxin Type A: Analysis of Adverse Event Reports From the USA, Europe, Canada, and Australia

A bibliometric analysis of the global research landscape on artificial intelligence applications in clinical medicine (2010–2025)

Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system

Strengthening pharmacovigilance through patient reporting: a scoping review of awareness, barriers, and facilitators

Safety of treatment regimens for drug-resistant TB over a 15-year period: a scoping review

A causal machine learning framework for pharmacovigilance signal detection in electronic health records: Drug-induced acute kidney injury

Serious Adverse Drug Reactions Associated with Off-Label and Unlicensed Drug Use in Children: A 14-Year Analysis of VigiBase Reports from Serbia

Too stressed to cope? A multiple mediation analysis of social bonds, sleep quality, and sleep disturbances in relation to prescription drug use among Chinese high school seniors

Pharmacists want action on fake weight-loss jabs

Pharmacovigilance Study of Drug-Related Renal Vascular Lesions Based on FAERS and Experimental Exploration

Real-world pharmacovigilance insights and clinical safety signal characterization of the classic mood stabilizer‑lithium carbonate: A disproportionality analysis based on FAERS data

AI-augmented pharmacovigilance for cardio-oncology: FDR- controlled disproportionality and anomaly detection of antineoplastic-associated cardiac events in FAERS (2015 Q1–2025 Q4)

Reproductive Toxicity of Rifampicin and Isoniazid on Male Reproductive System-A Review

Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes

Ensuring patient rights, safety, and welfare in “compassionate use” of drugs

The evolution of ethical and legal regulations of drug research

Barriers to Adverse Drug Reaction Reporting Among Physicians, Nurses, and Pharmacists: A Scoping Review Comparing High-Income Versus Low-/Middle-Income Countries

Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment

Pemphigoid associated with quinolone antibiotics: A real-world pharmacovigilance study of the FDA Adverse Event Reporting System and literature-based evidence

Patient Safety in Nuclear Medicine: Work Process Analysis From the SEIPS Model Perspective

Society for Maternal‐Fetal Medicine Special Statement: Assessment and management of reported penicillin allergy in pregnancy

Characterization of the Adverse Drug Reactions Associated with Psychotropic Medications Based on a Spontaneous Reporting Systems Database: A Retrospective Analysis

Early Evaluation of the Food and Drug Administration (FDA) Adverse Event Monitoring System (AEMS): An Analysis of Over 32 Million Pharmacovigilance Reports

Sex Differences in Psychotropic Drug Exposure and Safety: A Systematic Review Toward Personalized Dosing Strategies

Drug-induced fever: a pharmacovigilance analysis based on the FDA adverse event reporting system

ROLE OF TOXICOKINETICS IN IMPROVING DRUG SAFETY

Putting FAERS data into perspective: cautionary considerations for comparative safety assessment

Development of a European Union Time-Indexed Reference Dataset for Assessing the Performance of Signal Detection Methods in Pharmacovigilance using a Large Language Model

Drivers and strategies to combat substandard and falsified medicines in low-and middle-income countries: A systematic review of qualitative evidence

MHRA and eBay working in partnership to safeguard public health

A patient safety escape room simulation for internal medicine learners, based on hazards identified in local incident reports

Regional Trends in the Opioid Epidemic Using Safety Signals of Drug Abuse and Dependence: A Disproportionality Analysis Using VigiBase

Artificial Intelligence in Personalized Breast Cancer Drug Safety: From Preclinical Toxicology to Clinical Risk Management

Counterfeiters cash in on the world’s bestselling cancer drug

CEPI and PAHO expand partnership to strengthen regulatory systems and vaccine safety across the Americas

AI-Driven Cybersecurity Architectures for Pharmaceutical Manufacturing and Supply Chains

Association study of aromatase inhibitors and adverse events related to osteoporosis: based on pharmacovigilance data

Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system

Consciousness Disturbances Reported With Clindamycin Versus Cefazolin in Surgical Patients: A Global Pharmacovigilance Analysis Using VigiBase

Deep Learning Approaches to ADMET Prediction: Improving Drug Safety and Pharmacokinetics

“Making One's Own Doctor”:“Épicerie medicine” and the Informal Circulation of Antibiotics in Northern Madagascar

Drug resistant fungi warning

Efficacy and Safety of Intrathecal Buprenorphine for Postoperative Analgesia in Cesarean Delivery: A Systematic Review of Randomized Controlled Trials

Pharmacovigilance analysis of vaccination errors during pregnancy using VAERS data

Decoding adverse event signals of folic acid supplementation in cardiac patients: a stratified pharmacovigilance analysis based on FAERS

Adverse Drug Reaction Detection on Social Media Based on Large Language Models

A hierarchical risk assessment framework for head-to-head comparison of statin safety profiles in Chinese patients

Thalidomide memorial activity: pedagogies of creativity, joy and immersion in medical education

Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndrome

Boletín sobre Medicamentos Veterinarios. Enero-Marzo 2026

Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing

Clínic Barcelona reaches over 1,000 adverse drug reaction reports through a pioneering pharmacovigilance programme

Hyaluronic Acid Products Containing Undeclared Ingredients

Changes in Mifepristone Use at Pharmacies After Removal of the FDA In-Person Dispensing Requirement

Can Genes Affect GLP-1 Side Effects and Treatment Outcomes?

Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage Cancer

Surveillance of antimicrobial resistance by a global network of WHO collaborating centres

Discontinuation of Levothyroxine in Adults Aged 60 Years or Older

GLP-1 Drugs Under Scrutiny: How Real Are the Risks?

Updated EMA-HMA workplan on data and AI in medicines regulation 2026 to 2028

Sexual Safety Signals of Common Antidiabetic Drugs: Insights From FAERS Disproportionality Analysis

US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008–2022)

Real-World Safety Signals of Drug-Induced Proteinuria: A Two-Decade Pharmacovigilance Study Using Multi-Indicator Detection and Multivariate Correction

Gastrointestinal adverse events associated with tirzepatide: A bibliometric and pharmacovigilance analysis

Safety profile and signal detection of tadalafil: a real-world analysis based on the Food and Drug adverse event reporting system

Assessing Research Impact With Bibliometrics and Altmetrics: The Case of the Canadian Network for Observational Drug Effect Studies (CNODES)

Safety and Effectiveness of Contezolid versus Linezolid in Drug-Resistant Tuberculosis: A 12-Month Retrospective Study from China

Performance-enhancing drug use in sports: a Bayesian variable selection and profile regression approach to identifying risk factors and estimating prevalence

Adverse drug reactions among children with tuberculosis in China: a multicentre study, 2017–2022

Integrating precision medicine and artificial intelligence to prevent cardiotoxicity in cardiovascular drug therapy

EMA recommends restricting use of Tecovirimat SIGA

Efficacy, safety, route of administration of midazolam and diazepam for pediatric status epilepticus: systematic review, meta-analysis, and trial sequential analysis

Patterns of antibiotic-induced cutaneous adverse drug reactions in a tertiary care hospital in India: A retrospective observational study

Safety Profile and Adverse Drug Reactions of Radium-223 in the EudraVigilance Database: A Retrospective Descriptive Analysis

Advancing pharmacoepidemiology and pharmacovigilance: A scoping review of challenges, technological innovations, and global strategies for drug safety

Adverse and Serious Adverse Events Associated With Tocilizumab in COVID-19 Pneumonia and With Cyclosporin, Pazopanib, and Insulin Glargine in Other Diseases: A Single-Center Cross-Sectional Study From a Tertiary Care Center in Bangladesh

International Society of Pharmacovigilance Advances over Time: Strategies and Results of the Advisory Board from 2022 to 2025

Content analysis of illegal online advertisements for hypertension-related drugs and supplements in Taiwan

Risk assessment for cardiovascular adverse drug events in the ICU: Case study on COVID-19 patients

Effectiveness and safety of bedaquiline, pretomanid, linezolid and moxifloxacin in drug-resistant tuberculosis patients in selected public hospitals in Ethiopia: a multicenter retrospective cohort study

Nationwide assessment of community pharmacists’ practices and atorvastatin–drug interactions in Egypt

Boletín sobre Seguridad de Medicamentos de Uso Humano. Enero de 2026

A Qualitative Exploration of the Perspectives on Medication Error Among Healthcare Professionals

Effects of the COVID-19 pandemic on antibiotic use and resistance in French hospitals, 2019–22: a retrospective ecological analysis of national surveillance data